Tuesday, 20 May 2008
Subscribe to:
Post Comments (Atom)
skip to main |
skip to sidebar
NEWS AND VIEWS FROM THE PHARMACEUTICAL FINE CHEMICAL AND CUSTOM MANUFACTURING SECTOR
Fine
The FINE blog keeps you up-to-date on the pharmaceutical fine chemical and custom manufacturing sector. The weekly FINE Newsletter gives senior pharmaceutical fine chemical and custom manufacturing leaders a weekly summary of the key news stories and trends for the sector. The FINE Newsletter and blog focus on coverage of companies in the pharmaceutical fine chemical custom manufacturing sector, without forgetting key news from their customers in the pharma industry.
Subscribe
To receive the newsletter, each week, please subscribe.
Advertising
|
|
|
|
||
| Read this FREE online! Full Book | PDF Summary | Podcast | ||
Blog Archive
-
▼
2008
(457)
-
▼
May
(47)
- Angel Biotechnology will manufacture clinical-grad...
- Jubilant Organosys has completed its acquisition o...
- Safety concerns slow FDA approvals
- Cytovance Biologics will manufacture an antibody f...
- FDA awaits China approval
- Chemtura for sale?
- Lonza has acquired Amaxa AG to enhance its Cell Di...
- Sumitomo Chemical to build 10,000 tonne/year resor...
- Draxis shareholders approve acquisition by Jubilan...
- SAFC Pharma to manufacture Oncolytics Biotech's Re...
- Unipex Group has acquired the active ingredients a...
- Dr Reddy's reveals Dowpharma and BASF costs
- SOCMA certifies facilities
- Cobra Biomanufacuring wins vaccine manufacturing a...
- FDA to get subpoena powers?
- FMC to buy ISP alginates business
- Sill four for Evonik
- Nicholas Piramal wants further custom manufacturin...
- FDA bars Scientific Laboratories from manufacturin...
- Chemicals help Evonik to 11% rise in Q1 sales
- Evonik to invest €2.5bn in chemicals unit
- FDA confirms China plans, will ban exporters
- Chemie Uetikon launches biotech division
- Anu's Laboratories sees IPO subscribed eight times
- FDA approves BASF excipient
- FDA NME approvals at all time low rate
- SynCo Bio Partners has completed the manufacture o...
- Major expansion
- FDA asks for cash
- Albemarle plans fine chems acquisitions
- Biopharma CMO market grows
- Ampac Fine Chemicals sees 36% rise in sales in qua...
- Jubilant Organosys has acquired pyridine derivativ...
- Agilent expands nucleic acid capacity, buys Dow te...
- Dishman expands API capacity
- Dr Reddy's plans more acquisitions
- Cobra Biomanufacturing raises £1m to upgrade its O...
- Anu's to invest in plants
- Reaxa launches second generation encapsulated cata...
- AMRI sees sales rise, completes high potency facility
- QSV Biologics will manufacture a recombinant prote...
- Dr Reddy's completes Dowpharma and BASF acquisitions
- Cambrex Q1 sales drop 5%
- Albemarle to move HQ to Baton Rouge
- Pfizer, finally, confirms biologics facility in Ir...
- FDA Director back-tracks
- Wacker's fine chemicals business sees 21% fall in ...
-
▼
May
(47)
Technorati
Copyright ©2007, 2008 FINE. All rights reserved.
No comments:
Post a Comment